Skip to main content
Nancy Rigotti, MD, Internal Medicine, Boston, MA

NancyAnnRigottiMD

Internal Medicine Boston, MA

Hospital Medicine/Hospitalist

Professor of Medicine, Massachusetts General Hospital

Dr. Rigotti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rigotti's full profile

Already have an account?

  • Office

    55 Fruit St
    # YAW4720B
    Boston, MA 02114
    Phone+1 617-724-6700
    Fax+1 617-726-2894

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1982 - 1986
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1978 - 1981
  • Harvard Medical School
    Harvard Medical SchoolClass of 1978

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1980 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • JACC Focus Seminar: CV Health Promotion JACC Focus Seminar Prevention and Treatment of Tobacco Use: JACC Health Promotion Series  
    Neal L Benowitz, Nancy A Rigotti, Sara Kalkhoran, ScienceDirect

Lectures

  • E-cigs and Vapes: What to Say When Patients Ask? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Pearls In Lifestyle Related Prevention Every Cardiology Practitioner Needs to Know 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Approaches to Help Your Patient Quit Smoking 
    58th Annual Scientific Session & Expo, Orlando, Florida, USA
  • Join now to see all

Other

Authored Content

  • Monitoring the Rapidly Changing Landscape of E-cigarettesAugust 2018

Press Mentions

  • Treatment with Cytisinicline Shows Benefit in E-cigarettes Cessation for Participants: Phase 2 ORCA-V1 Trial
    Treatment with Cytisinicline Shows Benefit in E-cigarettes Cessation for Participants: Phase 2 ORCA-V1 TrialMay 7th, 2023
  • Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
    Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingMarch 3rd, 2023
  • How to Support Smoking Cessation After Hospital Discharge
    How to Support Smoking Cessation After Hospital DischargeAugust 10th, 2022
  • Join now to see all

Grant Support

  • Comparative Effectiveness Of Post-Discharge Strategies For Hospitalized SmokersNational Heart, Lung, And Blood Institute2012
  • Smoking Interventions For Hospital Patients:A Comparative Effectiveness TrialNational Heart, Lung, And Blood Institute2009–2010
  • Smoking Cessation Interventions For Health Care SettingsNational Heart, Lung, And Blood Institute2005–2009
  • Bupropion For Smoking Cessation In Postpartum WomenNational Institute On Drug Abuse2006–2007
  • Bupropion For Early Intervention To Stop Tobacco Use In Heart DiseaseNational Center For Research Resources2004
  • Smoking Cessation In Interventions For Hospital PatientsNational Heart, Lung, And Blood Institute2000–2004
  • Bupropion To Stop Tobacco Use In Heart DiseaseNational Center For Research Resources2000–2002
  • Bupropion For Hospitalized Smokers W Coronary DiseaseNational Heart, Lung, And Blood Institute1999–2002
  • Preventive OncologyNational Cancer Institute1994–1996
  • Preventive Oncology Academic AwardNational Cancer Institute1992–1993
  • Analysis Of Laws Restricting Smoking In Public PlacesNational Cancer Institute1988

Professional Memberships